基本信息
views: 101
Career Trajectory
Bio
RESEARCH OVERVIEW
Molecular mechanisms of chemo- and radiotherapy-induced cell death and tumor cell intrinsic resistance mechanisms.
Molecular mechanisms of microenvironment-mediated treatment resistance.
The phosphatidylinositol-3-kinase pathway as a target for the modulation of the therapy response.
Molecular mechanisms of radiation-induced pneumonitis.
Focus areas
The Institute of Cell Biology comprises 5 working groups: Molecular Cell Biology, Molecular Genetics, Molecular Developmental Biology, The BioChip Lab, and the DNA Repair Lab. Research at the Institute of Cell Biology focuses on basic academic research in the areas of cancer development and cancer treatment. All of the Institutes groups aim to shed light on the molecular mechanisms of cancer development, utilizing various methodological and thematic approaches. The ultimate goal is to provide the basis for cause-oriented clinical treatments. To this end, the Institute's employees work with state-of-the-art methods of biotechnology and molecular biology.
Fields of Research
Characterization of molecular mechanisms of stress-induced cell death in both tumor and normal tissues
Identification of mechanisms of resistance
Development of targeted strategies for the modulation of chemo and radiation sensitivity in both tumor and normal tissue cells
Analysis of normal B cell development and differentiation in humans
Study of the development of B cell lymphomas, including, but not limited to, Hodgkins lymphoma
Molecular mechanisms of chemo- and radiotherapy-induced cell death and tumor cell intrinsic resistance mechanisms.
Molecular mechanisms of microenvironment-mediated treatment resistance.
The phosphatidylinositol-3-kinase pathway as a target for the modulation of the therapy response.
Molecular mechanisms of radiation-induced pneumonitis.
Focus areas
The Institute of Cell Biology comprises 5 working groups: Molecular Cell Biology, Molecular Genetics, Molecular Developmental Biology, The BioChip Lab, and the DNA Repair Lab. Research at the Institute of Cell Biology focuses on basic academic research in the areas of cancer development and cancer treatment. All of the Institutes groups aim to shed light on the molecular mechanisms of cancer development, utilizing various methodological and thematic approaches. The ultimate goal is to provide the basis for cause-oriented clinical treatments. To this end, the Institute's employees work with state-of-the-art methods of biotechnology and molecular biology.
Fields of Research
Characterization of molecular mechanisms of stress-induced cell death in both tumor and normal tissues
Identification of mechanisms of resistance
Development of targeted strategies for the modulation of chemo and radiation sensitivity in both tumor and normal tissue cells
Analysis of normal B cell development and differentiation in humans
Study of the development of B cell lymphomas, including, but not limited to, Hodgkins lymphoma
Research Interests
Papers共 335 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CELL DEATH DISCOVERYno. 1 (2024)
Maja Guberina,Christoph Poettgen,Nika Guberina,Christian Hoffmann,Marcel Wiesweg,Cedric Richlitzki,Martin Metzenmacher,Clemens Aigner, Servet Boeluekbas,Thomas Gauler,Wilfried E. E. Eberhardt,Michael Forsting,Ken Herrmann,Dirk Theegarten,Kaid Darwiche,Verena Jendrossek,Martin Stuschke,Martin Schuler
Cancersno. 6 (2024): 1174-1174
Cell death and diseaseno. 1 (2024)
Sied Kebir, Vivien Ullrich, Pia Berger,Celia Dobersalske, Sarah Langer,Laurèl Rauschenbach,Daniel Trageser,Andreas Till,Franziska K. Lorbeer, Anja Wieland,Timo Wilhelm-Buchstab, Ashar Ahmad, Holger Fröhlich, Igor Cima,Shruthi Prasad,Johann Matschke,Verena Jendrossek, Marc Remke, Barbara M. Grüner, Alexander Roesch,Jens T. Siveke,Christel Herold-Mende,Tobias Blau,Kathy Keyvani, Frank K.H. van Landeghem,Torsten Pietsch, Jörg Felsberg,Guido Reifenberger,Michael Weller,Ulrich Sure,Oliver Brüstle,Matthias Simon,Martin Glas,Björn Scheffler
crossref(2023)
STRAHLENTHERAPIE UND ONKOLOGIE (2023): S167-S168
Cited0Views0Bibtex
0
0
Sied Kebir, Vivien Ullrich, Pia Berger,Celia Dobersalske, Sarah Langer,Laurèl Rauschenbach,Daniel Trageser,Andreas Till,Franziska K. Lorbeer, Anja Wieland,Timo Wilhelm-Buchstab, Ashar Ahmad, Holger Fröhlich, Igor Cima,Shruthi Prasad,Johann Matschke,Verena Jendrossek, Marc Remke, Barbara M. Grüner, Alexander Roesch,Jens T. Siveke,Christel Herold-Mende,Tobias Blau,Kathy Keyvani, Frank K.H. van Landeghem,Torsten Pietsch, Jörg Felsberg,Guido Reifenberger,Michael Weller,Ulrich Sure,Oliver Brüstle,Matthias Simon,Martin Glas,Björn Scheffler
crossref(2023)
Kristina Zec,Stephanie Thiebes,Jenny Bottek,Devon Siemes,Philippa Spangenberg,Duc Viet Trieu, Nils Kirstein,Nirojah Subramaniam,Robin Christ,Diana Klein,Verena Jendrossek,Maria Loose,Florian Wagenlehner,Jadwiga Jablonska,Thilo Bracht,Barbara Sitek,Bettina Budeus,Ludger Klein-Hitpass,Dirk Theegarten,Olga Shevchuk,Daniel R. Engel
Frontiers in immunology (2023)
NEOPLASIA (2023): 100892-100892
STRAHLENTHERAPIE UND ONKOLOGIE (2023): S36-S37
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 336
#Citation: 7564
H-Index: 52
G-Index: 79
Sociability: 8
Diversity: 0
Activity: 2
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn